Defucosylated Chimeric Anti-Cc Chemokine Receptor 4 IgG1 With Enhanced Antibody-Dependent Cellular Cytotoxicity Shows Potent Therapeutic Activity to T-Cell Leukemia and Lymphoma
Cancer Research - United States
doi 10.1158/0008-5472.can-03-2068
Full Text
Open PDFAbstract
Available in full text
Date
March 15, 2004
Authors
Publisher
American Association for Cancer Research (AACR)